Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial.

"Conflict of interest: J.C.N. received institutional grants from the Novo Nordisk Foundation and the Danish Heart Foundation. J.B.J. is a consultant for Medtronic. M.V. serves on conduction system pacing advisory boards for Medtronic and Abbott. K.G.S. reports unrestricted research grants from Philips, Abbott, Merck, and Johnson & Johnson, and she is a consultant for Optum Labs and Abbott, Happify, and Haemonetics. K.G.S. is supported by NIH grants 1R21AT012430-01 (NCCIH) and 1R01HL163640-01A1 (NHLBI). J.A.S. has no conflicts of interest for the study but discloses providing consultative services on patient-reported outcomes and evidence evaluation to Alnylam, AstraZeneca, Bayer, Merck, Janssen, Bristol Meyers Squibb, Edwards, Kineksia, 4DT Medical, Terumo, Cytokinetics, Imbria, and United Healthcare. He holds research grants from Bristol Meyers Squibb, Abbott Vascular, and Janssen. He owns the copyright to the Seattle Angina Questionnaire, Kansas City Cardiomyopathy Questionnaire, and Peripheral Artery Questionnaire and serves on the Board of Directors for Blue Cross Blue Shield of Kansas City. All remaining authors have declared no conflicts of interest."

"Funding This work was funded by the Lundbeck Foundation, grant # R198-2015-175; TrygFonden, Grant # 109704; and Patient@Home seeding grant."